文献速递消化道肿瘤与早癌消化内镜

前瞻性多中心队列中非内镜Barrett食管检测算法的训练与测试

Algorithm Training and Testing for a Nonendoscopic Barrett's Esophagus Detection Test in Prospective Multicenter Cohorts.
PubMed 文献 · Clin Gastroenterol Hepatol · 2024-03-19

研究基于两个前瞻性多中心队列,使用3个甲基化DNA标志物(MDM)面板在胶囊海绵细胞采集装置(CCD)标本上训练并锁定算法,再在独立测试集中验证。训练集和测试集分别显示:特异度90%时敏感度82%,特异度84%时敏感度88%;高级别异型增生和食管腺癌(EAC)敏感度均为100%。结论认为该锁定算法对高风险Barrett食管(BE)病例在独立验证样本中表现出优异敏感度。

要点

  • 3-MDM面板(NDRG4、VAV3、ZNF682)在CCD标本上检测BE/EAC,训练集特异度90%时敏感度82%。
  • 测试集特异度84%时敏感度88%,高级别异型增生和EAC敏感度均为100%。
  • 长段BE敏感度90%,短段BE敏感度68%;非异型增生BE总体敏感度82%。

核心结论

  • 锁定的3-MDM面板算法使用非内镜CCD检测BE/EAC,在独立验证样本中对高风险BE病例表现出优异敏感度。

研究设计与样本

  • 算法训练和测试样本来自2个前瞻性多中心队列;所有BE病例均有食管肠化生(伴或不伴异型增生/EAC),对照无内镜下BE证据。
  • CCD操作后行内镜;从CCD细胞裂解液中提取DNA、亚硫酸氢盐处理并盲法检测MDM。
  • 使用交叉验证逻辑回归在训练集设定并锁定算法,在独立测试集评估性能;训练集N=352,测试集N=125。

主要发现

  • 最终面板包含3个MDM:NDRG4、VAV3、ZNF682。
  • 训练集总体敏感度82%(95% CI,68%-94%),特异度90%(79%-98%);测试集敏感度88%(78%-94%),特异度84%(70%-93%)。
  • 长段BE敏感度90%,短段BE敏感度68%。
  • 高级别异型增生和EAC的敏感度在训练集和测试集均为100%。
  • 非异型增生BE总体敏感度82%;BE检测的ROC曲线下面积在训练集和测试集分别为0.92和0.94。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Endoscopic Barrett's esophagus (BE) and esophageal adenocarcinoma (EAC) detection is invasive and expensive. Nonendoscopic BE/EAC detection tools are guideline-endorsed alternatives. We previously described a 5-methylated DNA marker (MDM) panel assayed on encapsulated sponge cell collection device (CCD) specimens. We aimed to train a new algorithm using a 3-MDM panel and test its performance in an independent cohort. METHODS: Algorithm training and test samples were from 2 prospective multicenter cohorts. All BE cases had esophageal intestinal metaplasia (with or without dysplasia/EAC); control subjects had no endoscopic evidence of BE. The CCD procedure was followed by endoscopy. From CCD cell lysates, DNA was extracted, bisulfite treated, and MDMs were blindly assayed. The algorithm was set and locked using cross-validated logistic regression (training set) and its performance was assessed in an independent test set. RESULTS: Training (N = 352) and test (N = 125) set clinical characteristics were comparable. The final panel included 3 MDMs (NDRG4, VAV3, ZNF682). Overall sensitivity was 82% (95% CI, 68%-94%) at 90% (79%-98%) specificity and 88% (78%-94%) sensitivity at 84% (70%-93%) specificity in training and test sets, respectively. Sensitivity was 90% and 68% for all long- and short-segment BE, respectively. Sensitivity for BE with high-grade dysplasia and EAC was 100% in training and test sets. Overall sensitivity for nondysplastic BE was 82%. Areas under the receiver operating characteristic curves for BE detection were 0.92 and 0.94 in the training and test sets, respectively. CONCLUSIONS: A locked 3-MDM panel algorithm for BE/EAC detection using a nonendoscopic CCD demonstrated excellent sensitivity for high-risk BE cases in independent validation samples. (Clinical trials.gov: NCT02560623, NCT03060642.).

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Iyer PG, Slettedahl SW, Mahoney DW, et al. Algorithm Training and Testing for a Nonendoscopic Barrett's Esophagus Detection Test in Prospective Multicenter Cohorts. Clin Gastroenterol Hepatol. 2024. PMID: 38513982. doi:10.1016/j.cgh.2024.03.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。